Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Research Services
Sydney, Please Select-based ANZUP Cancer Trials Group Limited operates in Research Services. It is a nonprofit, and its site is anzup.org.au. It holds one address on record, all in Australia. Headcount on record is 32. Its work is tagged urogenital and prostate cancer trials and testicular, kidney and bladder. One Australian registration (ABN) is a confirmed match. It is listed alongside nine similar brands, mostly in Research Services.
ABN32133634956
| ANZUP Cancer Trials Group Limited | ABN 32133634956 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Welcome to the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group. Our mission is to conduct clinical trial research to improve treatment of bladder, kidney, testicular, penile and prostate cancers.
Funded by Cancer Australia ANZUP is a cancer cooperative clinical trials group, established to bring together all the professional disciplines and groups involved in researching and treating urogenital cancers. We saw a gap and a need for an organisation able to perform clinical trials based on the best science and with clear input from Australian and New Zealand researchers and the general community. ANZUP was established in 2008 and has clearly demonstrated its value and promise by performing investigator-initiated clinical trials, developed by our members, both nationally and internationally across the range of genitourinary cancers. We continue to build on our impressive multidisciplinary membership while developing very strong relationships with other NGO’s such as Prostate Cancer Foundation of Australia, CanSpeak, Cancer Councils, the national cancer cooperative trials groups, COSA, Kidney Health Australia as well as Government and Industry.
We collaborate with the NHMRC Clinical Trials Centre at the University of Sydney on a number of ANZUP studies. Through ANZUP and our research collaborations we are able to encourage participation of clinicians and researchers in the development, conduct, evaluation, and promotion of clinical trials and translate research outcomes into future clinical practice to improve health outcomes and the quality of life for our patients.
Membership of ANZUP is open to anyone holding the ideals of ANZUP and working in the field of cancer care or cancer research in a professional capacity. In particular we would like to encourage trainees in the various clinical and scientific disciplines to join and to participate in the scientific and strategic development of ANZUP.
Please refer to our website.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One New South Wales entity on the ABR: ANZUP Cancer Trials Group Limited (ABN 32 133 634 956), high confidence.
32 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Australia only. Primary: Level 8, Tower 3, 300 Barangaroo Avenue, Sydney, Please Select 2550.
None linked to this brand.
Four tags on the brand's own list, among them Urogenital and prostate cancer trials and testicular, kidney and bladder.
13 profiles list ANZUP Cancer Trials Group Limited as a peer. It lists ten peers of its own. Thoracic Oncology Group of Australasia and Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute list it back.